Our observation of approximately one third of cancers demonstrating loss of PTEN expression is in keeping with other reports which have identified 20-40% of CRC as PTEN expression negative [16,17], as is our observation of low PTEN mutation rates that have been reported in previous studies. This evidence concerns the gene PTEN and colorectal carcinoma.